Biotech Values

[DewDiligence]

Re: Pfizer survey

>I thought the choice of replies lacked the issue which might become 'the' most exciting thing about PFE during 2006,-Acquiring a generic company as a platform, in order to lead the generic market.<

I can’t rule that out, but it didn’t even occur to me to include such an answer choice in the survey. PFE has not shown much interest in generic drugs beyond the use of “authorized” generics for their own patented products.

Unlikely, IMHO, that PFE makes a large acquisition in the generic arena in 2006.